What do we know about duloxetine's mode of action? Evidence from animals to humans

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 113, Issue SUPPL. 1, 2006, Pages 5-9

  Schuessler, B ^a  

^a LUZERNER KANTONSSPITAL   (Switzerland)

Author keywords

5 HT; Duloxetine; NA; Serotonin and noradrenalin reuptake inhibitor; Urethral closure

Indexed keywords

DULOXETINE; GLUTAMIC ACID; NORADRENALIN; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

COUGHING; DRUG EFFICACY; DRUG MECHANISM; HUMAN; MICTURITION; MOTONEURON; MUSCLE RELAXATION; NERVE CELL EXCITABILITY; NEUROMODULATION; NONHUMAN; PRIORITY JOURNAL; PUDENDAL NERVE; REVIEW; SACRAL SPINAL CORD; SMOOTH MUSCLE TONE; STRESS INCONTINENCE; URETHRA; VALSALVA MANEUVER;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; FEMALE; HUMANS; MODELS, ANIMAL; SEROTONIN UPTAKE INHIBITORS; THIOPHENES; URETHRA; URINARY INCONTINENCE, STRESS;

EID: 33644889657     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2006.00877.x     Document Type: Review

References (23)

1. Abrams P Cardozo L Fall M Griffiths D Rosier P Ulmsten U et al The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society Urology 2003 61 37 49
2. Fultz NH Burgio K Diokno AC Kinchen KS Obenchain R Bump RC Burden of stress urinary incontinence for community-dwelling women Am J Obstet Gynecol 2003 189 1275 82
3. Hunskaar S Lose G Sykes D Voss S The prevalence of urinary incontinence in women in four European countries BJU Int 2004 93 324 30
4. DeLancey JO Ashton-Miller JA Pathophysiology of adult urinary incontinence Gastroenterology 2004 126 1 Suppl 1 S23 32
5. Mostwin J Bourcier A Haab F Koelbl H Rao S Resnick NM et al Pathophiology of urinary incontinence, fecal incontinence and pelvic organ prolapse In Abrams P Cardozo L Khoury S Wein A editors Incontinence 3rd edn Plymouth, UK Plymbridge Distributors Ltd 2005 p 423 84
6. Stahl SM Mechanism of action of serotonin selective reuptake inhibitors. Serotonin receptors and pathways mediate therapeutic effects and side effects J Affect Disord 1998 51 215 35
7. Thor KB Serotonin and norepinephrine involvement in efferent pathways to the urethral rhabdosphincter: implications for treating stress urinary incontinence Urology 2003 62 4 Suppl 1 3 9
8. Collins SL Moore RA McQuay HJ Wiffen P Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review J Pain Symptom Manage 2000 20 449 58
9. McCormack PL Keating GM Duloxetine: in stress urinary incontinence Drugs 2004 64 2567 73
10. Waldinger MD Olivier B Utility of selective serotonin reuptake inhibitors in premature ejaculation Curr Opin Investig Drugs 2004 5 743 7
11. Michel MC Ruhé HG de Groot AA Castro R Oelke M Tolerability of amine uptake inhibitors in urologic diseases Curr Drug Saf 2006 1 73 85
12. Viktrup L Bump RC Pharmacological agents used for the treatment of stress urinary incontinence in women Curr Med Res Opin 2003 19 485 90
13. Michel MC Peters SL Role of serotonin and noradrenaline in stress urinary incontinence BJU Int 2004 94 Suppl 1 23 30
14. Thor KB Katofiasc MA Effects of duloxetine, a combined serotonin and norepinephrine reuptake inhibitor, on central neural control of lower urinary tract function in the chloralose-anesthetized female cat J Pharmacol Exp Ther 1995 274 1014 24
15. Thor KB Targeting serotonin and norepinephrine receptors in stress urinary incontinence Int J Gynaecol Obstet 2004 86 Suppl 1 S38 52
16. Cardozo L Drutz HP Baygani SK Bump RC Pharmacological treatment of women awaiting surgery for stress urinary incontinence Obstet Gynecol 2004 104 511 19
17. Dmochowski RR Miklos JR Norton PA Zinner NR Yalcin I Bump RC Duloxetine versus placebo for the treatment of North American women with stress urinary incontinence J Urol 2003 170 1259 63
18. Ghoniem GM Van Leeuwen JS Elser DM Freeman RM Zhao YD Yalcin I et al A randomized controlled trial of duloxetine alone, pelvic floor muscle training alone, combined treatment and no active treatment in women with stress urinary incontinence J Urol 2005 173 1647 53
19. Millard RJ Moore K Rencken R Yalcin I Bump RC Duloxetine vs placebo in the treatment of stress urinary incontinence: a four-continent randomized clinical trial BJU Int 2004 93 311 18
20. Norton PA Zinner NR Yalcin I Bump RC Duloxetine versus placebo in the treatment of stress urinary incontinence Am J Obstet Gynecol 2002 187 40 48
21. van Kerrebroeck P Abrams P Lange R Slack M Wyndaele JJ Yalcin I et al Duloxetine versus placebo in the treatment of European and Canadian women with stress urinary incontinence BJOG 2004 111 249 57
22. Boy S Reitz A Wirth B Karsenty G Knapp P Schurch B Facilitatory neuromodulative effect of duloxetine on urethral sphincter motor neurons in healthy females Eur Urol Suppl 2005 4 253 Abstract 998
23. Bump RC Benson JT Yalcin I Zhao YD Peng G Biomechanical and electrophysiological effects of duloxetine in women with stress urinary incontinence 2004 Accessed 2004